Evidence map›Paper›PMID 29939488›Full record

ArticleJournal of the International AIDS Society2018

Prevention paradox: Medical students are less inclined to prescribe HIV pre-exposure prophylaxis for patients in highest need.

Sarah K Calabrese, Valerie A Earnshaw, Kristen Underhill, Douglas S Krakower, Manya Magnus, Nathan B Hansen, Kenneth H Mayer, Joseph R Betancourt, Trace S Kershaw, John F Dovidio

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Qualitative investigation of factors impacting pre-exposure prophylaxis initiation and adherence in sexual minority men.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

Sarah K CalabreseDepartment of Psychology, George Washington University, Washington, DC, USA.ORCID 0000-0003-2640-0208
Valerie A EarnshawDepartment of Human Development and Family Studies, University of Delaware, Newark, DE, USA.
Kristen UnderhillColumbia Law School, Columbia University, New York, NY, USA.
Douglas S KrakowerThe Fenway Institute, Fenway Health, Boston, MA, USA.
Manya MagnusDepartment of Epidemiology and Biostatistics, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
Nathan B HansenDepartment of Health Promotion and Behavior, College of Public Health, University of Georgia, Athens, GA, USA.
Kenneth H MayerThe Fenway Institute, Fenway Health, Boston, MA, USA.ORCID 0000-0001-7460-733X
Joseph R BetancourtDisparities Solutions Center, Massachusetts General Hospital, Harvard Medical School, Harvard University, Boston, MA, USA.
Trace S KershawSocial and Behavioral Sciences Department, Yale School of Public Health, Yale University, New Haven, CT, USA.
John F DovidioSocial and Behavioral Sciences Department, Yale School of Public Health, Yale University, New Haven, CT, USA.
Beth Israel Deaconess Medical Center · USYale University · USColumbia University · USGeorge Washington University · USHarvard University · USMilken Institute · USUniversity of Delaware · USUniversity of Georgia · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI John Edward Pachankis · 2001 to 2026
$48.5M
SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Italo Mocchetti · 2015 to 2026
$29.6M
Optimizing HIV Pre-Exposure Prophylaxis through Shared Decision MakingK23MH098795 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KRAKOWER, DOUGLAS SCOTT · 2012 to 2016
$873k
PrEP for HIV Prevention in MSM: Mixed-Methods Study of Behavior & Message FramingK01MH093273 · NIMH · YALE UNIVERSITY · PI UNDERHILL, KRISTEN · 2011 to 2015
$873k
Understanding and Addressing Disclosure to Members of Social Networks among People Recovering from Substance Use DisordersK01DA042881 · NIDA · UNIVERSITY OF DELAWARE · PI EARNSHAW, VALERIE ANN · 2017 to 2020
$756k
Intervention to Promote PrEP Awareness and Equitable Prescription among ProvidersK01MH103080 · NIMH · YALE UNIVERSITY · PI CALABRESE, SARAH K. · 2014 to 2017
$634k
NIAID NIH HHS P30 AI060354NIAID NIH HHS P30 AI117970NIDA NIH HHS K01 DA042881NIMH NIH HHS K01 MH093273NIMH NIH HHS K01 MH103080NIMH NIH HHS K23 MH098795NIMH NIH HHS P30 MH062294
6 · The paper itself

Abstract

introductionDespite healthcare providers' growing awareness of pre-exposure prophylaxis (PrEP), prescription rates remain low. PrEP is an efficacious HIV prevention strategy recommended for use with condoms but still protective in their absence. Concern about the impact of PrEP on condom use and other risk behaviour is, nonetheless, among the barriers to prescription commonly reported. To understand the implications of this concern for PrEP access, we examined how medical students' willingness to prescribe PrEP varied by patients' condom use and partnering practices. We also assessed the perceived acceptability of various reasons for condom discontinuation with PrEP.

methodsAn online survey was distributed to 854 medical students in the Northeastern US in 2015. Participants (n = 111) were surveyed about their willingness to prescribe PrEP for each of six male patients who systematically differed in their reported condom use (sustained use, sustained nonuse, or discontinuation with PrEP) and partnering practices (single male partner with untreated HIV or multiple male partners of unknown HIV status). Participants also reported perceived acceptability of four reasons for condom discontinuation: pleasure, sexual functioning, intimacy, and conception.

resultsWillingness to prescribe PrEP was inconsistent with patient risk: When the patient used condoms and planned to sustain condom use, most participants were willing to prescribe PrEP - 93% if the patient had a single partner and 86% if the patient had multiple partners. Fewer were willing to prescribe if the patient did not use condoms and planned to sustain nonuse (53% and 45%, respectively) or used condoms but planned to discontinue use (27% and 28%). Significantly fewer participants were willing to prescribe for a patient with multiple partners versus a single partner when the patient reported sustained condom use or sustained condom nonuse. The number of participants who were willing to prescribe was similarly low for a patient with multiple partners versus a single partner when the patient reported that he planned to discontinue condom use. More participants accepted a patient discontinuing condoms for conception (69%) than for intimacy (23%), pleasure (14%), or sexual functioning (13%).

conclusionMedical students' clinical judgments were misaligned with patient risk and suggest misconceptions or personal values may undermine provision of optimal HIV prevention services.

Indexed as

Pre-Exposure ProphylaxisStudents, MedicalAdultCondomsDrug PrescriptionsFemaleHIV InfectionsHumansMalehealthcare disparitieshealth personnelHIVpre-exposure prophylaxisprescriptionssexual minorities

Identifiers

PMID29939488
PMCPMC6016621
OpenAlexW2809872158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.